Not surprising - the Board is mostly US based and they are more likely to get access to funds and to big pharmas in the US
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%